Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aurinia Pharmaceuticals Inc
AUPH
Healthcare
Biotechnology
Aurinia Pharmaceuticals Inc. is a Canada-based fully integrated biopharmaceutical company. The Company is focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. The Company has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis...
(LN) and continues to conduct pre-clinical, clinical, and regulatory activities to support the voclosporin development program. LUPKYNIS is a calcineurin inhibitor (CNI) immunosuppressant, that improves near and long-term outcomes in LN when used in combination with mycophenolate mofetil (MMF) and steroids. LUPKYNIS reduces cytokine activation and blocks interleukin IL-2 expression and T-cell mediated immune responses. Voclosporin, the active ingredient in LUPKYNIS, is made by a modification of a single amino acid of the cyclosporine molecule. Its product pipeline includes AUR200 and AUR300.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:AUPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(398)
•••
jboom70
X
View Profile
View Bullboard History
Comment by
jboom70
on Oct 25, 2021 8:42am
RE:Buyout?
No one here? I see $45-$50 buyout but hope for a staight share for share with Bristol as they have pulled back. Thoughts?
(398)
•••
jboom70
X
View Profile
View Bullboard History
Post by
jboom70
on Oct 22, 2021 4:27pm
Buyout?
We will see the price.
Fresh Insight into the Topaz Helium Project's Expected Size and Scale
posted Apr 26, 2024 9:00am by
Pulsar Helium Inc.
-
|
The prospective zone is very broad. We believe its not just an isolated occurrence but is actually something quite regionally extensive ...read more
(0)
•••
kimstos
X
View Profile
View Bullboard History
Comment by
kimstos
on Oct 01, 2021 5:14am
RE:Decent Q2 results
Same opinion here. Several valuable patents, giving them access to the market for rare diseases. Further, they already had the success with FDA on their product, and started to commercialize it in the
...more
(398)
•••
jboom70
X
View Profile
View Bullboard History
Post by
jboom70
on Sep 12, 2021 3:44pm
Painful
Wait. If we can get over $20.50 this will really fly.
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Post by
ZoranSto
on Aug 06, 2021 2:44pm
Decent Q2 results
Looks like they are on their way to some great future revenue....unfortuneatly we will now have to trade only on nasdaq
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Post by
ZoranSto
on Jun 03, 2021 9:46am
Insider buying
Lots of insider buying recently....good sign and could account for the recent run up.....Once they start actually showing some decent revenue this will be well over $20 a share....just taking a little
...more
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Comment by
ZoranSto
on May 07, 2021 12:52pm
RE:Aurinia Reports First Quarter 2021 Financial Results
I see the market was very disappointed with the progress to commercialize the drug. Sure hope they make better progress for Q2
(189)
•••
biggerr
X
View Profile
View Bullboard History
Post by
biggerr
on Mar 28, 2021 12:47pm
Lupkynis and Covid
If this Lupkynis drug suppresses the production of the cytokine by the body why don't they use it in the treatment of the severe Covid cases when they have the "cytokine storm"?
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Comment by
ZoranSto
on Mar 23, 2021 12:58pm
RE:RE:Globe & Mail
Should be.....just waiting until they start selling and adding revenue. They seem to be on schedule.
(13)
•••
LowtoHigh
X
View Profile
View Bullboard History
Comment by
LowtoHigh
on Mar 22, 2021 9:39pm
RE:Globe & Mail
Just entered for the first time. Hope it will be a profitable ride!
(6043)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 15, 2021 9:08am
Globe & Mail
06:11 AM EDT, 03/15/2021 (MT Newswires) -- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH and TSX: AUP) was at last look up about 3% in US pre-market after announcing a "favorable" assessment
...more
(398)
•••
jboom70
X
View Profile
View Bullboard History
Post by
jboom70
on Mar 15, 2021 7:50am
News
link
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Comment by
ZoranSto
on Mar 05, 2021 11:24am
RE:Projected Return
Projections are not looking good this week.
(6043)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 02, 2021 12:47pm
Projected Return
Top of the list. GLTA Listed below is a complete list of all 219 companies in the S&P/TSX composite index grouped by sector and ranked based on their expected price returns (excluding dividend or
...more
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Comment by
ZoranSto
on Mar 01, 2021 7:40am
RE:Shorts Still a Factor
Maybe its time to start a reddit post and squeeze those shorts....
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update